Health
Vaccine by Christmas amid record cases in the US – News Mail
The Oxford vaccine trial has produced a positive response, as more than half US states reported their highest day of new cases.
A vaccine candidate for COVID-19 developed by the University of Oxford with the backing of pharmaceutical giant AstraZeneca has produced positive results.
The test jabs have triggered robust immune responses in adults.
According to Bloomberg, findings from blood tests which were carried out on a group of older trial participants reinforce data released in July which suggest the vaccine is effective for adults aged between 18 and 55, Astra announced on Monday local time.
Results from the study show…
-
General19 hours agoWondering about winter | The Spectator Australia
-
Noosa News18 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General18 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business23 hours agoAre Domain Holdings shares undervalued?